[DOI] [PubMed] [Google Scholar] 62.Cai D., Li Q.Q., Chu C., Wang S.Z., Tang Y.T., Appleton A.A., Qiu R.L., Yang B.Y., Hu L.W., Dong G.H., et al
E.SiegelE
The 7-day mortality rate and daily mouse weights were tracked, and the LD 50 of CGA injection was determined as previously described (Schlede et al., 1992)
16 ChenY.ZhangP.ChenW.ChenG
Oral Formulation Technology Capsule Formulation Design: The oral BPC-157 capsule formulation employs specific design features to optimize peptide delivery and research applications: Encapsulation Materials: HPMC capsule shells provide vegetarian, gastric-resistant properties Pharmaceutical-grade excipients selected for peptide stability Desiccant packaging to prevent moisture-induced degradation Light-resistant packaging to protect photosensitive residues Formulation Rationale: Encapsulation serves multiple research purposes including standardized administration for comparative studies, protection during storage and handling, and investigation of release kinetics in simulated gastrointestinal conditions